CAS 2138299-29-1

(E)-1-(4-(5-Carbamoyl-2-(1-ethyl-3-methyl-1H-pyrazole-5-carboxamido)-1H-benzo[d]imidazol-1-yl)but-2-en-1-yl)-2-(1-ethyl-3-methyl-1H-pyrazole-5-carboxamido)-7-(3-hydroxypropoxy)-1H-benzo[d]imidazole-5-

CAS: 2138299-29-1

(E)-1-(4-(5-Carbamoyl-2-(1-ethyl-3-methyl-1H-pyrazole-5-carboxamido)-1H-benzo[d]imidazol-1-yl)but-2-en-1-yl)-2-(1-ethyl-3-methyl-1H-pyrazole-5-carboxamido)-7-(3-hydroxypropoxy)-1H-benzo[d]imidazole-5-

Purity: 98%

Molecular weight: 750.82g/mol

Ref: 54-OR1074649

Sting agonist-3

CAS: 2138299-29-1

Sting agonist-3 is a cytotoxic agent that binds to extracellular nucleic acid. It is used in the treatment of systemic inflammation, such as sepsis and chronic obstructive pulmonary disease. Sting agonist-3 has been shown to modulate the immune response by increasing the production of myeloid cells, which are important for fighting infections. This agent also inhibits tumor growth by inducing apoptosis and inhibiting tumor cell proliferation. Sting agonist-3 has been shown to be an anticancer drug with anti-cancer activity in animal models that may be due to its ability to inhibit cancer cell proliferation and induce apoptosis.

Formula: C₃₇H₄₂N₁₂O₆

Purity: Min. 95%

Molecular weight: 750.8 g/mol

Ref: 3D-NKD29929

STING agonist-3

CAS: 2138299-29-1

STING agonist-3: non-nucleotide, selective, anti-tumor with pEC50=7.5, pIC50=9.5, could enhance cancer therapy.

Formula: C₃₇H₄₂N₁₂O₆

Purity: 98%

Color and Shape: Solid

Molecular weight: 750.81

Ref: TM-T13014